Global Transdermal Testosterone Market Size, Share & Trends Analysis Report, By Type (Gel, Patch, and Solution), By Application (Primary Hypogonadism, Hypogonadotropic Hypogonadism, and Late-Onset Hypogonadism), Forecast (2022-2028)

The global transdermal testosterone market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Testosterone transdermal, also known as a patch, is used for the treatment of males whose bodies do not make enough natural testosterone; a condition called hypogonadism. Testosterone is a male hormone responsible for the growth and development of the male sex organs and maintenance of secondary sex characteristics. These transdermal contain testosterone, which is delivered through the skin for treatment of low testosterone levels. This form of topical patch is used for the treatment of males whose bodies do not make enough natural testosterone; a condition called hypogonadism. Low levels of testosterone in men may lead to the occurrence of chronic fatigue, erectile dysfunction, decreased sexual desire, osteoporosis, and the relapse of secondary sexual features, among other conditions. Since testosterone is defined as a male hormone responsible for the development and growth of the male sex organs and maintenance of secondary sex characteristics, these patches synthetically support in the above-mentioned functions.

The growth of the global transdermal testosterone market is likely to boosted by the new product launches. For instance, in September 2018, Ferring Pharmaceuticals declared the launch of Testavan 20 mg/g transdermal gel for the treatment of adult male hypogonadism. Testavan is a new testosterone replacement therapy designed to restore testosterone levels to a normal range (300-1050 ng/dL) in adult males with hypogonadism. Testavan provides male hypogonadism sufferers with a new treatment option to support restore testosterone levels. It is a topical gel with a patented formulation, based on Ferring’s Advanced Skin Technology (F.A.S.T.), that is designed to provide optimal absorption and bioavailability.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Type
• By Application

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape: AbbVie Inc., Teva Pharmaceutical Industries Ltd., and Lupin Ltd., among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Transdermal Testosterone Market Report by Segmentation

By Type

• Gel
• Patch
• Solution

By Application

• Primary Hypogonadism
• Hypogonadotropic Hypogonadism
• Late-Onset Hypogonadism